FDA Adverse Event Other Summary report: N

DUROM US ACETABULAR COMPONENT 52/46 L

MDR report key: 2181532 · Received July 6, 2011

Report

Report Number
9613350-2011-00449
Event Type
Other
Date Received
July 6, 2011
Report Date
June 17, 2011
Manufacturer
ZIMMER GMBH
Product Code
KWA
Removal / Correction Number
C9613350-07/15/2008-001
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
PA, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

INFORMATION WAS FORWARDED FROM (B)(6) WHICH MARKETS THE DEVICES IN THE U.S. THE MANUFACTURER DID NOT RECEIVE EXPLANTED DEVICES, X-RAYS, OR OTHER SOURCE DOCUMENTS FOR REVIEW. WHERE LOT NUMBERS WERE RECEIVED FOR THE EXPLANTED DEVICES, THE DEVICE HISTORY RECORDS WERE REVIEWED AND FOUND TO BE CONFORMING. WHILE A CAUSE FOR THIS SPECIFIC CLINICAL EVENT CANNOT BE ASCERTAINED FROM THE INFORMATION PROVIDED, THE COMMON CLINICAL PRESENTATION AND THE DATE OF THE ORIGINAL IMPLANTATION SUGGEST THAT THE REVISION SURGERY IS RELATED TO THE ISSUES FOR WHICH ZIMMER IMPLEMENTED A CORRECTION IN (B)(4) 2008. SHOULD ADDITIONAL INFORMATION BECOME AVAILABLE AND/OR THE DEVICE(S) BE RETURNED FOR EVALUATION AND AN INVESTIGATION RESULT BE AVAILABLE, THAT CHANGES THIS ASSESSMENT, AN AMENDED MEDICAL DEVICE REPORT WILL BE FILED. THE NEED FOR FURTHER CORRECTIVE MEASURES IS NOT INDICATED AT THIS TIME AND ZIMMER (B)(4) CONSIDERS THIS CASE CLOSED. (B)(4).

Description of Event or Problem · 1

IT IS REPORTED THAT THE PATIENT UNDERWENT TOTAL LEFT HIP ARTHROPLASTY ON (B)(6) 2008. IT WAS ALSO REPORTED THAT POST OP THE PATIENT EXPERIENCED PAIN AND LOOSENING. SURGICAL REVISION WAS CONDUCTED ON (B)(6) 2009.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 DUROM US ACETABULAR COMPONENT 52/46 L DUROM ACETABULAR COMPONENT AND METASUL KWA ZIMMER GMBH 2342247

Patients

Seq Age Sex Outcome Treatment
1 66 YR Other